Skip to main content
. 2023 Jun 9;13(6):739. doi: 10.3390/metabo13060739

Table 1.

Toxic effects of microplastic exposure on laboratory mice.

Properties of Microplastics Used Toxicity Reference
Polystyrene microplastics (5–20 μm)
  • Accumulated in the kidney, liver, and intestine of mice, and the highest bioaccumulation factor was found in the intestine

[74]
Polystyrene microplastics (5 μm)
  • Accumulated in the intestinal tissues and also reduced intestinal mucus secretion and impaired intestinal barrier function

  • Changes in the intestinal flora diversity with a significant decrease in actinomycetes

  • Significant changes in metabolic pathways such as pyruvate metabolism, tyrosine metabolism, and fatty acid biosynthesis

[26]
Polystyrene nanoplastics (0.5 μm)
  • Increased liver weight, liver index, and liver function indicators

  • Up-regulation of interferon-γ, TNF-α, IL-1β, IL-6, and IL-33 mRNA expression in non-parenchymal hepatocytes

  • Down-regulation of IL-4, IL-5, IL-10, IL-18, and transforming growth factor-β1 expression

[75]
Polystyrene microplastics (5 μm)
  • Accumulated in the liver tissue accompanied by tissue vacuolar degeneration, chronic inflammatory cell infiltration, and hepatocellular edema

  • Decreased T-SOD, CAT, and GSH activities and increased MDA levels

  • L02 hepatocyte rate of apoptosis increased

[76]
Polystyrene micro- and nanoplastics (0.5 μm and 50 μm)
  • Reduced body weight, liver weight, and lipid weight in the mice

  • Decreased intestinal mucus secretion

  • Relative abundance of Firmicutes and α-Protebacteri were reduced

  • Lower liver triglyceride and total cholesterol levels

  • Decreased mRNA levels of certain key genes associated with adipogenesis and triglyceride synthesis

[77]
Polystyrene microplastics (10–150 μm)
  • Increased abundance of Staphylococcus and decreased abundance of Paramecium

  • Elevated IL-1α levels

  • The small intestine showed a significant inflammatory response, as well as increased expression of TLR4, AP-1, and IRF526

[78]
Polystyrene microplastics (5 μm and 20 μm)
  • Accumulation in both the kidney and intestine, with tissue accumulation kinetics and distribution patterns dependent on microplastic particle size

  • Caused disturbances in energy and fat metabolism, as well as causing oxidative stress and neurotoxic reactions

[24]
Polyethylene micro- and nanoplastics (3–16 μm, 100 nm, and 600 nm)
Polystyrene micro- and nanoplastics (10 μm, 40 nm, and 250 nm)
  • Increased ROS generation

[79]
Polypropylene microplastics (<200 μm)
  • Elevated IL-6 and TNF-α levels

  • Elevated ROS levels

  • Caused erythrocyte hemolysis in a concentration-dependent manner

  • Increased the secretion of histamine, which induces allergic reactions at the cellular level

[80]
Polystyrene microplastics (1 μm, 4 μm, and 10 μm)
  • Accumulation in the intestinal tract

  • Causes a decrease in cell viability at higher concentrations

  • Macrophage uptake of microplastics was followed by polarization

[81]
Polystyrene nanoplastics (23–26 nm)
  • Accumulation in the mouse brain

  • Changes in anxiety-like behavior and anti-predator defense responses in the face of predators

  • Reduced DPPH radical scavenging activity and reduced total GSH content

  • Appearance of DNA damage

[82]
Polystyrene microplastics (5 μm)
  • Caused metabolic disorders, intestinal flora dysbiosis, and intestinal barrier dysfunction in the mother

  • Caused intergenerational effects with long-term metabolic consequences in the F1 and F2 mice

  • The possibility of hepatic lipid accumulation in the F1 generation mouse in adulthood

[83]